Table 4. Characteristics of the patients who were sampled and those who had received antivirals.
| All swabs (n = 648) | Received antivirals (n = 6) | Not received antivirals (n = 642) | |
|---|---|---|---|
| Sex | |||
| Males | 263 (40.6%) | 3 (50%) | 260 (40.5%) |
| Females | 385 (59.4%) | 3 (50%) | 382 (59.5%) |
| Age | |||
| 0–17 years | 233 (36.0%) | 1 (16.7%) | 232 (36.1%) |
| 18–64 years | 349 (53.8%) | 5 (83.3%) | 344 (53.6%) |
| ≥65 years | 66 (10.2%) | 0 | 66 (10.3%) |
| Ethnicity | |||
| White ethnicity | 396 (61.1%) | 3 (50%) | 393 (61.2%) |
| All other ethnicity | 66 (10.2%) | 1 (16.7%) | 65 (10.1%) |
| Ethnicity unknown | 186 (28.7%) | 2 (33.3%) | 184 (28.7%) |
| IMD Quintile | |||
| 1 (most deprived) | 41 (6.3%) | 0 | 41 (6.4%) |
| 2 | 64 (9.9%) | 0 | 64 (9.9%) |
| 3 | 120 (18.5%) | 4 (66.6%) | 116 (18.1%) |
| 4 | 188 (29.0%) | 1 (16.7%) | 187 (29.1%) |
| 5 (least deprived) | 216 (33.3%) | 1 (16.7%) | 215 (33.5%) |
| Unknown | 19 (3.0%) | 0 | 19 (3.0%) |
| Risk group | |||
| Y | 175 (27.0%) | 3 (50%) | 172 (26.8%) |
| N | 473 (73.0%) | 3 (50%) | 470 (73.2%) |
| Average number of GP visits in last 12 months | 27.6 | 28.8 | 27.5 |
| (95% CI: 25.7–29.5) | (95% CI: 19.5–38.2) | (95% CI: 25.6–29.5) | |
| Average number hospitalisations in last 12 months | 1.4 | 1.3 | 1.4 |
| (95% CI: 1.3–1.5) | (95% CI: 0.7–2.0) | (95% CI: 1.3–1.5) | |
| Influenza vaccination in last season | |||
| Y | 181 (27.9%) | 3 (50.0%) | 178 (27.7%) |
| N | 467 (72.1%) | 3 (50.0%) | 464 (72.3%) |
| Pregnant | |||
| Y | 11 (1.7%) | 0 | 11 (2.0%) |
| N | 637 (98.3%) | 6 (100%) | 631 (98.0%) |
| Pneumococcal vaccination | |||
| Y | 177 (27.3%) | 3 (50.0%) | 174 (27.1%) |
| N | 471 (72.7%) | 3 (50.0%) | 468 (72.9%) |